Studies show that orexin is a strong modulator of depression and anxiety states (Johnson et al., 2010, 2012; Lungwitz et al., 2012), and locomotor activity (Burgess, 2010; Kosse et al., 2017). Here, HCRT is linked to depressive disorder.